Boston Scientific (BSX) Misses Q1 EPS by 1c, Beats on Revenue; Lowers FY EPS Guidance, Raises FY Revenue Guide

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. ACN
3. FFAI
4. STI
5. MCD
6. PAA
7. PAGP
8. WBD
9. FAN
10. COHR

Go back to Boston Scientific (BSX) Misses Q1 EPS by 1c, Beats on Revenue; Lowers FY EPS Guidance, Raises FY Revenue Guide

Boston Scientific (BSX) PT Raised to $30 at Needham & Company

April 27, 2017 3:58 PM EDT

Needham & Company raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $29.00) while maintaining a Buy rating.

... More

Boston Scientific (BSX) PT Raised to $30 at Stifel

April 27, 2017 3:55 PM EDT

Stifel raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $28.00) while maintaining a Buy rating.

... More

Boston Scientific (BSX) PT Raised to $31 at Cowen

April 27, 2017 1:03 PM EDT

Cowen raised its price target on Boston Scientific (NYSE: BSX) to $31.00 (from $29.00) while maintaining a Outperform rating amid "robust" top-line performance.

Analyst Joshua Jennings said the reason the company gave for the margin shortfall - non-recurring expenses- is "very plausible" and they... More

Boston Scientific (BSX) PT Raised to $28.50 at Evercore ISI; Revenue Beat was 'Remarkable'

April 27, 2017 12:00 PM EDT

Evercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $26.50) while maintaining a Outperform rating after the company "curshed" it on revenues for the quarter.

Analyst Vijay Kumar, "In large cap land, organic revenue beats of >400 bps... More